4.7 Article

Disruption of innate defense responses by endoglycosidase HPSE promotes cell survival

Journal

JCI INSIGHT
Volume 6, Issue 7, Pages -

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/jci.insight.144255

Keywords

-

Funding

  1. NIH [R01EY024710, R01EY029426, F30EY025981, P30EY001792]

Ask authors/readers for more resources

The drive to withstand environmental stresses and defend against invasion is a universal trait in all forms of life, but how signaling pathways interface to generate coordinated responses to diverse stimuli remains unclear. Research on heparanase reveals its role in disease development and its ability to counteract pathogen invasion through multiple defense mechanisms.
The drive to withstand environmental stresses and defend against invasion is a universal trait extant in all forms of life. While numerous canonical signaling cascades have been characterized in detail, it remains unclear how these pathways interface to generate coordinated responses to diverse stimuli. To dissect these connections, we followed heparanase (HPSE), a protein best known for its endoglycosidic activity at the extracellular matrix but recently recognized to drive various forms of late-stage disease through unknown mechanisms. Using herpes simplex virus-1 (HSV-1) infection as a model cellular perturbation, we demonstrate that HPSE acts beyond its established enzymatic role to restrict multiple forms of cell-intrinsic defense and facilitate host cell reprogramming by the invading pathogen. We reveal that cells devoid of HPSE are innately resistant to infection and counteract viral takeover through multiple amplified defense mechanisms. With a unique grasp of the fundamental processes of transcriptional regulation and cell death, HPSE represents a potent cellular intersection with broad therapeutic potential.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

The 3-O-sulfation of heparan sulfate modulates protein binding and lyase degradation

Pradeep Chopra, Apoorva Joshi, Jiandong Wu, Weigang Lu, Tejabhiram Yadavalli, Margreet A. Wolfert, Deepak Shukla, Joseph Zaia, Geert-Jan Boons

Summary: This study introduced a modular synthetic approach to create diverse HS oligosaccharides with or without 3-OS. These oligosaccharides were used to examine ligand requirements for HS-binding proteins on a glycan microarray. The study also found that 3-OS influenced cleavage by lyase II while 2-OS only affected digestion by lyase I, showing varied substrate specificities among heparin lyases.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Biology

Perinatal granulopoiesis and risk of pediatric asthma

Benjamin A. Turturice, Juliana Theorell, Mary Dawn Koenig, Lisa Tussing-Humphreys, Diane R. Gold, Augusto A. Litonjua, Emily Oken, Sheryl L. Rifas-Shiman, David L. Perkins, Patricia W. Finn

Summary: This study identified specific perinatal characteristics associated with pediatric asthma risk and identified transcriptional changes as mediators of this risk. The abundance of neutrophil-specific granules at birth was found to predict risk for pediatric asthma and pulmonary function in adolescence.

ELIFE (2021)

Article Virology

Protease, Growth Factor, and Heparanase-Mediated Syndecan-1 Shedding Leads to Enhanced HSV-1 Egress

Ghadah A. Karasneh, Divya Kapoor, Navya Bellamkonda, Chandrashekhar D. Patil, Deepak Shukla

Summary: The increased levels of HPSE can reduce syncytial plaque formation and promote viral egress and release. Transiently enhanced expression of HPSE does not affect HSV-1 entry into cells but facilitates extracellular release of mature virions.

VIRUSES-BASEL (2021)

Article Multidisciplinary Sciences

OPTN is a host intrinsic restriction factor against neuroinvasive HSV-1 infection

Joshua Ames, Tejabhiram Yadavalli, Rahul Suryawanshi, James Hopkins, Alexander Agelidis, Chandrashekhar Patil, Brian Fredericks, Henry Tseng, Tibor Valyi-Nagy, Deepak Shukla

Summary: The study demonstrates that the autophagy receptor OPTN plays a crucial neuroprotective role during HSV-1 infection by degrading viral proteins, preventing virus spread and neuronal necroptosis. Lack of OPTN leads to cognitive decline and susceptibility to lethal CNS infection in mice, indicating its importance in survival from potentially deadly viral infections.

NATURE COMMUNICATIONS (2021)

Article Microbiology

Heparan Sulfate Binding Cationic Peptides Restrict SARS-CoV-2 Entry

Rahul K. Suryawanshi, Chandrashekhar D. Patil, Raghuram Koganti, Sudhanshu Kumar Singh, Joshua M. Ames, Deepak Shukla

Summary: Research indicates that cationic peptides G1 and G2 may inhibit the entry of SARS-CoV-2 by reducing the essential receptor HS on cell surfaces and interfering with the virus interaction with ACE2.

PATHOGENS (2021)

Editorial Material Cell Biology

OPTN (optineurin)-mediated selective autophagy prevents neurodegeneration due to herpesvirus infection

Chandrashekhar D. Patil, Deepak Shukla

Summary: Very little is known about the mechanisms that restrict neurotropic herpesviruses from infecting the central nervous system and causing neuron death. However, recent research has shown that OPTN-mediated autophagy acts as an intrinsic immune barrier against these viruses and protects the CNS from neurodegenerative stress.

AUTOPHAGY (2022)

Article Immunology

Intrinsic Antiviral Activity of Optineurin Prevents Hyperproliferation of a Primary Herpes Simplex Virus Type 2 Infection

Chandrashekhar D. Patil, Rahul Suryawanshi, Joshua Ames, Raghuram Koganti, Alex Agelidis, Divya Kapoor, Tejabhiram Yadavalli, Lulia Koujah, Henry C. Tseng, Deepak Shukla

Summary: This study reveals the key role of optineurin (OPTN) in restricting HSV-2 infection and controlling viral spread. Lack of OPTN leads to enhanced virus production and impaired host autophagy response. The OPTN/CCL5 nexus identified in this study may represent an intrinsic host defense mechanism against herpesviruses.

JOURNAL OF IMMUNOLOGY (2022)

Article Virology

Plasma Membrane-Derived Liposomes Exhibit Robust Antiviral Activity against HSV-1

Ilina Bhattacharya, Tejabhiram Yadavalli, David Wu, Deepak Shukla

Summary: This study demonstrates the antiviral activity of plasma membrane-derived liposomes, especially in preventing HSV-1 infection. The research shows that cellular liposomes expressing viral entry-specific cell surface protein receptors exhibit robust antiviral activity, while those lacking the relevant HSV-1 entry receptors do not.

VIRUSES-BASEL (2022)

Article Virology

CREB3 Plays an Important Role in HPSE-Facilitated HSV-1 Release in Human Corneal Epithelial Cells

Tejabhiram Yadavalli, Pankaj Sharma, David Wu, Divya Kapoor, Deepak Shukla

Summary: CREB3 plays a key role in HPSE-facilitated HSV-1 egress. HPSE expression is correlated with CREB3 expression, and HPSE-transfected cells show higher CREB3 expression, while HPSE knockout cells show lower CREB3 expression. CREB3-transfected cells exhibit significantly increased export of HPSE upon infection. Additionally, COPII, which mediates HPSE trafficking, is upregulated via a CREB3-dependent pathway during HSV-1 infection. Co-transfection of CREB3 and HPSE results in the highest viral release.

VIRUSES-BASEL (2022)

Article Multidisciplinary Sciences

ADAR1 mutation causes ZBP1-dependent immunopathology

Nicholas W. Hubbard, Joshua M. Ames, Megan Maurano, Lan H. Chu, Kim Y. Somfleth, Nandan S. Gokhale, Margo Werner, Jessica M. Snyder, Katrina Lichauco, Ram Savan, Daniel B. Stetson, Andrew Oberst

Summary: The RNA-editing enzyme ADAR1 inhibits innate immune activation and pathology by disrupting the duplex structure of endogenous double-stranded RNA species. Alteration of the Z-DNA-binding domain (ZBD) of ADAR1 leads to activation of ZBP1, causing autoinflammatory pathology.

NATURE (2022)

Article Multidisciplinary Sciences

Pathophysiology of reinfection by exogenous HSV-1 is driven by heparanase dysfunction

Rahul K. Suryawanshi, Chandrashekhar D. Patil, Alex Agelidis, Raghuram Koganti, Tejabhiram Yadavalli, Joshua M. Ames, Hemant Borase, Deepak Shukla

Summary: This study found that compared to animals lacking HPSE, wild-type mice exhibit notable pathophysiology during HSV-1 reinfection. HPSE promotes infected cell survival and supports the formation of a pro-disease environment. In contrast, lack of HPSE enhances intrinsic immunity by promoting cytokine expression, inducing necroptosis of infected cells, and decreasing leukocyte infiltration into the cornea. Overall, recent prior infection immunity fails to abolish disease manifestation during HSV-1 reinfection unless HPSE is rendered inactive.

SCIENCE ADVANCES (2023)

Article Medicine, Research & Experimental

Tolerability, pharmacokinetics, and anti-herpetic activity of orally administered BX795

Tejabhiram Yadavalli, Sudhanshu Kumar Singh, Abhijit A. Date, Deepak Shukla

Summary: This study evaluated the acute and short-term toxicity of orally administered BX795 in mice, as well as its pharmacokinetics and tissue distribution. The results showed that orally administered BX795 was well tolerated, had an oral bioavailability of 56%, and reached ocular and genital tissues within the first 15 min of dosing. The study indicated that orally administered BX795 can significantly reduce herpesvirus replication in ocular and genital tissue.

BIOMEDICINE & PHARMACOTHERAPY (2023)

No Data Available